ID

22046

Description

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site; ODM derived from: https://clinicaltrials.gov/show/NCT00360360

Link

https://clinicaltrials.gov/show/NCT00360360

Keywords

  1. 5/16/17 5/16/17 -
Uploaded on

May 16, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Neoplasm, Unknown Primary NCT00360360

Eligibility Neoplasm, Unknown Primary NCT00360360

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
biopsy proven metastatic carcinoma with the following light microscopic histologies: adenocarcinoma, poorly differentiated carcinoma(must have immunoperoxidase stains to rule out lymphoma, neuroendocrine carcinoma),or poorly differentiated squamous carcinoma.
Description

Metastatic Carcinoma Biopsy | Histology Light microscopy | Adenocarcinoma | Poorly differentiated carcinoma Immunoperoxidase stain | Lymphoma Excluded | Neuroendocrine Carcinoma Excluded | Squamous cell carcinoma Poorly differentiated

Data type

boolean

Alias
UMLS CUI [1,1]
C1384494
UMLS CUI [1,2]
C0005558
UMLS CUI [2,1]
C0344441
UMLS CUI [2,2]
C0430389
UMLS CUI [3]
C0001418
UMLS CUI [4,1]
C0741899
UMLS CUI [4,2]
C1441617
UMLS CUI [5,1]
C0024299
UMLS CUI [5,2]
C2828389
UMLS CUI [6,1]
C0206695
UMLS CUI [6,2]
C2828389
UMLS CUI [7,1]
C0007137
UMLS CUI [7,2]
C0205617
ecog performance status 0-1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
no previous treatment with any systemic therapy
Description

systemic therapy

Data type

boolean

Alias
UMLS CUI [1]
C1515119
adequate kidney, liver and bone marrow function
Description

Renal function | Liver function | Bone Marrow function

Data type

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0232741
UMLS CUI [3,1]
C0005953
UMLS CUI [3,2]
C0031843
be able to understand the nature of the study and give written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the following specific syndromes:
Description

Syndrome Specific

Data type

boolean

Alias
UMLS CUI [1,1]
C0039082
UMLS CUI [1,2]
C0205369
neuroendocrine carcinoma
Description

Carcinoma, Neuroendocrine

Data type

boolean

Alias
UMLS CUI [1]
C0206695
women with adenocarcinoma isolated to axillary lymph nodes
Description

Gender | Adenocarcinoma Isolated Axillary lymph nodes

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0001418
UMLS CUI [2,2]
C0205409
UMLS CUI [2,3]
C0729594
women with adenocarcinoma isolated to peritoneal involvement
Description

Gender | Adenocarcinoma Isolated Involvement peritoneal

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0001418
UMLS CUI [2,2]
C0205409
UMLS CUI [2,3]
C1314939
UMLS CUI [2,4]
C0442034
carcinoma involving only one site with resectable tumors at that site
Description

Carcinoma Involving Site Single | Neoplasms Resectable Site

Data type

boolean

Alias
UMLS CUI [1,1]
C0007097
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C1515974
UMLS CUI [1,4]
C0205171
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C1514888
UMLS CUI [2,3]
C1515974
squamous carcinoma limited to cervical, supraclavicular, or inguinal lymph nodes
Description

Squamous cell carcinoma Limited Cervical lymph nodes | Squamous cell carcinoma Limited Supraclavicular lymph nodes | Squamous cell carcinoma Limited Inguinal lymph nodes

Data type

boolean

Alias
UMLS CUI [1,1]
C0007137
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0588054
UMLS CUI [2,1]
C0007137
UMLS CUI [2,2]
C0439801
UMLS CUI [2,3]
C0229730
UMLS CUI [3,1]
C0007137
UMLS CUI [3,2]
C0439801
UMLS CUI [3,3]
C0729596
uncontrolled brain metastases and all patients with meningeal involvement
Description

Metastatic malignant neoplasm to brain Uncontrolled | Involvement meningeal

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C1314939
UMLS CUI [2,2]
C0521400
women pregnant or lactating
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
clinically significant cardiovascular disease
Description

Cardiovascular Disease

Data type

boolean

Alias
UMLS CUI [1]
C0007222
history of myocardial infarction or stroke within 6 months
Description

Myocardial Infarction | Cerebrovascular accident

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0038454
clinical history of hemoptysis or hematemesis
Description

Hemoptysis | Hematemesis

Data type

boolean

Alias
UMLS CUI [1]
C0019079
UMLS CUI [2]
C0018926
patients with peg tubes or g-tubes
Description

Percutaneous endoscopic tube | Gastrostomy tube

Data type

boolean

Alias
UMLS CUI [1]
C2985542
UMLS CUI [2]
C0150595
proteinuria
Description

Proteinuria

Data type

boolean

Alias
UMLS CUI [1]
C0033687
history of bleeding diathesis or coagulopathy
Description

Bleeding tendency | Blood Coagulation Disorders

Data type

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0005779
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have. you can then decide if you wish to participate.
Description

Clinical Trial Eligibility Criteria Additional | Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062
UMLS CUI [2]
C2348568

Similar models

Eligibility Neoplasm, Unknown Primary NCT00360360

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Metastatic Carcinoma Biopsy | Histology Light microscopy | Adenocarcinoma | Poorly differentiated carcinoma Immunoperoxidase stain | Lymphoma Excluded | Neuroendocrine Carcinoma Excluded | Squamous cell carcinoma Poorly differentiated
Item
biopsy proven metastatic carcinoma with the following light microscopic histologies: adenocarcinoma, poorly differentiated carcinoma(must have immunoperoxidase stains to rule out lymphoma, neuroendocrine carcinoma),or poorly differentiated squamous carcinoma.
boolean
C1384494 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0344441 (UMLS CUI [2,1])
C0430389 (UMLS CUI [2,2])
C0001418 (UMLS CUI [3])
C0741899 (UMLS CUI [4,1])
C1441617 (UMLS CUI [4,2])
C0024299 (UMLS CUI [5,1])
C2828389 (UMLS CUI [5,2])
C0206695 (UMLS CUI [6,1])
C2828389 (UMLS CUI [6,2])
C0007137 (UMLS CUI [7,1])
C0205617 (UMLS CUI [7,2])
ECOG performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
systemic therapy
Item
no previous treatment with any systemic therapy
boolean
C1515119 (UMLS CUI [1])
Renal function | Liver function | Bone Marrow function
Item
adequate kidney, liver and bone marrow function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C0031843 (UMLS CUI [3,2])
Informed Consent
Item
be able to understand the nature of the study and give written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Syndrome Specific
Item
the following specific syndromes:
boolean
C0039082 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
Carcinoma, Neuroendocrine
Item
neuroendocrine carcinoma
boolean
C0206695 (UMLS CUI [1])
Gender | Adenocarcinoma Isolated Axillary lymph nodes
Item
women with adenocarcinoma isolated to axillary lymph nodes
boolean
C0079399 (UMLS CUI [1])
C0001418 (UMLS CUI [2,1])
C0205409 (UMLS CUI [2,2])
C0729594 (UMLS CUI [2,3])
Gender | Adenocarcinoma Isolated Involvement peritoneal
Item
women with adenocarcinoma isolated to peritoneal involvement
boolean
C0079399 (UMLS CUI [1])
C0001418 (UMLS CUI [2,1])
C0205409 (UMLS CUI [2,2])
C1314939 (UMLS CUI [2,3])
C0442034 (UMLS CUI [2,4])
Carcinoma Involving Site Single | Neoplasms Resectable Site
Item
carcinoma involving only one site with resectable tumors at that site
boolean
C0007097 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,3])
C0205171 (UMLS CUI [1,4])
C0027651 (UMLS CUI [2,1])
C1514888 (UMLS CUI [2,2])
C1515974 (UMLS CUI [2,3])
Squamous cell carcinoma Limited Cervical lymph nodes | Squamous cell carcinoma Limited Supraclavicular lymph nodes | Squamous cell carcinoma Limited Inguinal lymph nodes
Item
squamous carcinoma limited to cervical, supraclavicular, or inguinal lymph nodes
boolean
C0007137 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0588054 (UMLS CUI [1,3])
C0007137 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0229730 (UMLS CUI [2,3])
C0007137 (UMLS CUI [3,1])
C0439801 (UMLS CUI [3,2])
C0729596 (UMLS CUI [3,3])
Metastatic malignant neoplasm to brain Uncontrolled | Involvement meningeal
Item
uncontrolled brain metastases and all patients with meningeal involvement
boolean
C0220650 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1314939 (UMLS CUI [2,1])
C0521400 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
women pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Cardiovascular Disease
Item
clinically significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Myocardial Infarction | Cerebrovascular accident
Item
history of myocardial infarction or stroke within 6 months
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
Hemoptysis | Hematemesis
Item
clinical history of hemoptysis or hematemesis
boolean
C0019079 (UMLS CUI [1])
C0018926 (UMLS CUI [2])
Percutaneous endoscopic tube | Gastrostomy tube
Item
patients with peg tubes or g-tubes
boolean
C2985542 (UMLS CUI [1])
C0150595 (UMLS CUI [2])
Proteinuria
Item
proteinuria
boolean
C0033687 (UMLS CUI [1])
Bleeding tendency | Blood Coagulation Disorders
Item
history of bleeding diathesis or coagulopathy
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Additional | Study Subject Participation Status
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have. you can then decide if you wish to participate.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C2348568 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial